Targeted therapy of solid malignancies via HLA class II antigens: A new biotherapeutic approach?

Oncogene

Volumn 22, Issue 43, 2003, Pages 6564-6569

  Altomonte, Maresa ^a   Fonsatti, Ester ^a   Visintin, Alberto ^a   Maio, Michele ^a  

^a CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

Author keywords

HLA class II; Immunotherapy; Melanoma; MHC class II; Monoclonal antibodies; Signaling

Indexed keywords

HLA ANTIGEN; HLA ANTIGEN CLASS 2; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY;

ANTIGEN EXPRESSION; CANCER IMMUNOTHERAPY; DRUG TARGETING; HLA SYSTEM; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; MELANOMA CELL; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; SKIN CANCER; SOLID TUMOR; TUMOR CELL;

EID: 0242624621     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206960     Document Type: Review

References (94)

1. Albino AP, Houghton AN, Eisinger M, Lee JS, Kantor RR, Oliff AI and Old LJ. (1986). J. Exp. Med., 164, 1710-1722.
2. Altomonte M, Pucillo C, Damante G and Maio M. (1993). J. Immunol., 151, 5115-5122.
3. Altomonte M, Pucillo C and Maio M. (1999). J. Cell. Physiol., 179, 251-256.
4. Altomonte M, Visintin A, Tecce R, Pucillo C and Maio M. (2003). J. Cell. Physiol., in press.
5. Andrè P, Cambier JC, Wade TK, Raetz T and Wade WF. (1994). J. Exp. Med., 179, 763-768.
6. Angelisova P, Hilgert I and Horejsi V. (1994). Immunogenetics, 39, 249-256.
7. Bartek J, Petrek M, Vojtesek B, Bartkova J, Kovarik J and Rejthar A. (1987). Br. J. Cancer, 56, 727-733.
8. Bernard D, Maurizis JC, Ruse F, Chassagne J, Chollet P, Sauvezie B, de Latour M and Plagne R. (1984). Clin. Exp. Immunol., 56, 215-221.
9. Bernsen MR, Hakansson L, Gustafsson B, Krysander L, Rettrup B, Ruiter D and Hakansson A. (2003). Br. J, Cancer, 88, 424-431.
10. Brasanac D, Markovic-Lipkovski J, Hadzi-Djokic J, Muller GA and Muller CA. (1999). Neoplasma, 46, 173-178.
11. Brunner CA, Gokel JM, Riethmüller G and Johnson JP. (1991). Eur. J. Cancer, 27, 411-416.
12. Byrne SN and Halliday GM. (2003). Cancer Immunol. Immunother., 52, 396-402.
13. Cabrera T, Ruiz-Cabello F and Garrido F. (1995). Scand. J. Immunol., 41, 398-406.
14. Chang CH and Flavell RA. (1995). J. Exp. Med., 181, 765-767.
15. Chang ES and Sohn SS. (1995). J. Korean Med. Sci., 10, 334-341.
16. Chia CP, Khrebtukova I, McCluskey J and Wade WF. (1994). J. Immunol., 153, 3398-3407.
17. Chin KC, Mao C, Skinner C, Riley JL, Wright KL, Moreno CS, Stark GR, Boss JM and Ting JP. (1995). Immunity, 1, 687-697.
18. Concha A, Esteban F, Cabrera T, Ruiz-Cabello F and Garrido F. (1991). Semin. Cancer Biol., 2, 47-54.
19. Coral S, Pucillo C, Leonardi A, Fonsatti E, Altomonte M and Maio M. (1997). Cell Growth Differ., 8, 581-588.
20. Dechant M, Vidarsson G, Stockmeyer B, Repp R, Glennie MJ, Gramatzki M, van De Winkel JG and Valerius T. (2002). Blood, 100, 4574-4580.
21. Esteban F, Concha A, Huelin C, Pérez-Ayala M, Pedrinacci S, Ruiz-Cabello F and Garrido F. (1989). Int. J. Cancer, 43, 436-442.
22. Feinmesser M, Sulkes A, Morgenstern S, Sulkes J, Stern S and Okon E. (2000). J. Clin. Pathol., 53, 286-291.
23. Garban F, Truman JP, Lord J, Drénou B, Plumas J, Jacob MC, Sotto JJ, Charron D and Mooney N. (1998). Exp. Hematol., 26, 874-884.
24. Glew SS, Duggan-Keen M, Cabrera T and Stern PL. (1992). Cancer Res., 52, 4009-4016.
25. Goodwin BL, Xi H, Tejiram R, Eason DD, Ghosh N, Wright KL, Nagarajan U, Boss JM and Blanck G. (2001). Cell Growth Differ., 12, 327-335.
26. Gutierrez J, López-Nevot MA, Cabrera T, Oliva R, Esquivias J, Ruiz-Cabello F and Garrido F. (1987). Expl. Clin. Immunogenet, 4, 144-152.
27. Harton JA, Van Hagen AE and Bishop GA. (1995). Immunity, 3, 349-358.
28. Heike M, Schlaak J, Schulze-Bergkamen H, Heyl S, Herr W, Schmitt U, Schneider PM and Meyer zum Buschenfelde KH. (1996). J. Immunol., 156, 2205-2213.
29. Hilders CGJM, Munoz IM, Nooyen Y and Fleuren GJ. (1995). Gynecol. Oncol. Jun., 57, 366-375.
30. Hilton DA and West KP. (1990). Cancer, 15, 1154-1157.
31. Houck JR, Sexton FM and Zajdel G. (1990). Arch. Otolaryngol. Head Neck Surg., 116, 1181-1185.
32. Hurlimann J and Saraga P. (1985). Int J. Cancer, 35, 753-762.
33. Joachim E, Charchanti A, Stavropoulos NE, Skopelitou A, Athanassiou ED and Agnantis N. (2000). Histol. Histopathol., 15, 721-727.
34. Ishigami S, Aikou T, Natsugoe S, Hokita S, Iwashige H, Tokushige M and Sonoda S. (1998). Oncology, 55, 65-69.
35. Kern I, Steimle V, Siegrist CA and Mach B. (1995). Int. Immunol., 7, 1295-1299.
36. Koretz K, Moldenhauer G, Majdic O and Möller P. (1989). Int. J. Cancer., 44, 816-822.
37. Kunihiro M, Tanaka S, Haruma K, Yoshihara M, Sumii K, Kajiyama G and Shimamoto F. (1998). Oncology, 55, 326-333.
38. Laufer TM, Smiley ST, Ranger A, Clements VK, Ostrand-Rosenberg S and Glimcher LH. (1997). J. Immunol., 159, 5914-5920.
39. Lazaris AC, Theodoropoulos GE, Davaris PS, Panoussopoulos D, Nakopoulou L, Kittas C and Golematis Basil C. (1995). Dis. Colon Rectum, 38, 739-745.
40. Lazzaro B, Anderson AE, Kajdacsy-Balla A and Hessner MJ. (2001). Appl. Immunohistochem., 9, 234-241.
41. Levy S, Todd SC and Maecker HT. (1998). Annu. Rev. Immunol., 16, 89-109.
42. Lovig T, Andersen SN, Thorstensen L, Diep CB, Meling GI, Lothe RA and Rognum TO. (2002). Br. J. Cancer, 87, 756-762.
43. Lu Y, Tschickardt ME, Schmidt BJ and Blanck G. (1997). Immunol. Cell Biol., 75, 325-332.
44. Lucin K, Internicka Z and Joniic N. (1994). Pathol. Res. Pract., 190, 1134-1140.
45. Ma XC, Hattori T, Kushima R, Terata N and Kodama M. (1994). Acta Oncol., 33, 187-190.
46. Maio M, Gulwani B, Morgano A and Ferrone S. (1989). Int. J. Cancer, 44, 554-559.
47. Marsh SGE, Parham P and Barber LD. (2000). The HLA Facts Book. Academic Press: London, pp. 26-36.
48. Mattijssen V, De Mulder PHM, Schalkwijk L, Manni JJ, Van't Hof-Grootenboer B and Ruiter DJ. (1991). Int. J. Cancer, (Suppl) 6, 95-100.
49. Möller P, Mattfeldt T, Gross C, Schlosshauer P, Koch A, Koretz K, Moldenhauer G, Kaufmann M and Otto HF. (1989). Am. J. Pathol., 135, 73-83.
50. Morita M, Tanaka K, Kawanishi H, Tsuji M, Ookusa T, Takada H, Okamura A and Hioki K. (1995). J. Surg. Oncol., 59, 233-238.
51. Muhlethaler-Mottet A, Otten LA, Steimle V and Mach B. (1997). EMBO J., 16, 2851-2860.
52. Nabavi N, Freeman GJ, Gault A, Godfrey D, Nadler LM and Glimcher LH. (1992). Nature, 360, 266-268.
53. Nagy ZA, Huber B, Loaning C, Rauchenberger R, Reiffert S, Thomassen-Wolf E, Zahn S, Leyer S, Schier EM, Zahradnik A, Brunner C, Lobenwein K, Rattel B, Stanglmaier M, Hallek M, Wing M, Anderson S, Dunn M, Kretzschmar T and Tesar M. (2002). Nat. Med., 8, 801-807.
54. Natali PG, Giacomini P, Bigotti A, Imai K, Nicotra MR, Ng AK and Ferrone S. (1983). Cancer Res., 43, 660-668.
55. Norheim Andersen S, Rognum TO, Lund E, Meling GI and Hauge S. (1993). Br. J. Cancer, 68, 80-85.
56. Ostmeier H, Fuchs B, Otto F, Mawick R, Lippold A, Krieg V and Suter L. (1999). Cancer, 85, 2391-2399.
57. Ostmeier H, Fuchs B, Otto F, Mawick R, Lippold A, Krieg V and Suter L. (2001). Br. J. Dermatol., 145, 203-209.
58. Perez M, Cabrera T, Lopez Nevot MA, Gomez M, Peran F, Ruiz-Cabello F and Garrido F. (1986). J. Immunogenet., 13, 247-253.
59. Piskurich JF, Linhoff MW, Wang Y and Ting JP. (1999). Mol. Cell. Biol., 19, 431-440.
60. Piskurich JF, Wang Y, Linhoff MW, White LC and Ting JP. (1998). J. Immunol., 160, 233-240.
61. Reith W and Mach B. (2001). Annu. Rev. Immunol., 19, 331-373.
62. Renkvist N, Castelli C, Robbins PF and Parmiani G. (2001). Cancer Immunol. Immunother., 50, 3-15.
63. Ricaniadis N, Kataki A, Agnantis N, Androulakis G and Karakousis CP. (2001). Eur. J. Surg. Oncol., 27, 88-93.
64. Rognum TO, Brandtzaeg P and Thorud E. (1983). Br. J. Cancer, 48, 543-551.
65. Rubinstein E, Le Naour F, Lagaudriere-Gesbert C, Billard M, Conjeaud H and Boucheix C. (1996). Eur. J. Immunol., 26, 2657-2665.
66. Sadanaga N, Kuwano H, Watanabe M, Maekawa S, Mori M and Sugimachi K. (1994). Cancer, 74, 586-591.
67. Saito T, Kimura M, Kawasaki T, Sato S and Tomita Y. (1997). Cancer Lett., 115, 121-127.
68. Schick MR and Levy S. (1993). J. Immunol., 151, 4090-4097.
69. Scholl PR and Geha RS. (1994). Immunol. Today, 15, 418-422.
70. Schwab M, Shimada H, Joshi V and Brodeur GM. (2000). Pathology and Genetics of Tumours of the Nervous System. Kleihues P, Cabenee WK (eds). International Agency for Research on cancer: Lyon, pp. 153-161.
71. Si Z and Hersey P. (1993). Int. J. Cancer., 54, 37-43.
72. Steimle V, Otten LA, Zufferey M and Mach B. (1993). Cell, 75, 135-146.
73. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B and Mach B. (1994). Science, 265, 106-109.
74. Stockmeyer B, Schiller M, Repp R, Lorenz HM, Kalden JR, Gramatzki M and Valerius T. (2002). Br. J. Haematol., 118, 959-967.
75. St-Pierre Y, Nabavi N, Ghogawala Z, Glimcher LH and Watts TH. (1989). J Immunol., 143, 808-812.
76. Sumiyoshi K, Kuwano H, Watanabe M, Kitamura M, Toh Y and Sugimachi K. (1999). Oncol. Rep., 6, 301-306.
77. Szollosi J, Horejsi V, Bene L, Angelisova P and Damjanovich S. (1996). J. Immunol., 157, 2939-2946.
78. Taramelli D, Fossati G, Mazzocchi A, Delia D, Ferrone S and Parmiani G. (1986). Cancer Res., 46, 433-439.
79. Tatsumi T, Kierstead LS, Ranieri E, Gesualdo L, Schena FP, Finke JH, Bukowski RM, Brusic V, Sidney J, Sette A, Logan TF, Kasamon YL, Slingluff Jr CL, Kirkwood JM and Storkus WJ. (2003). Clin. Cancer Res., 9, 947-954.
80. Ting JP, Wright KL, Chin KC, Brickey WJ and Li G. (1997). J. Immunol., 159, 5457-5462.
81. Trieb K, Lechleitner T, Lang S, Windhager R, Kotz R and Dirnhofer S. (1998). Pathol. Res. Pract., 194, 679-684.
82. Truman JP, Choqueux C, Charron D and Mooney N. (1996a). Cell. Immunol., 172, 149-157.
83. Truman JP, Garban F, Choqueux C, Charron D and Mooney N. (1996b). Exp. Hematol., 24, 1409-1415.
84. van der Stoep N, Biesta P, Quinten E and van den Elsen PJ. (2002). Int. J. Cancer, 97, 501-507.
85. van Duinen SG, Ruiter DJ, Broecker EB, van der Velde EA, Sorg C, Welvaart K and Ferrone S. (1988). Cancer Res., 48, 1019-1025.
86. Vora AR, Rodgers S, Parker AJ, Start R, Rees RC and Murray AK. (1997). Br. J. Cancer, 76, 836-844.
87. Wade WF, Davoust J, Salamero J, Andre P, Watts TH and Cambier JC. (1993). Immunol. Today, 14, 539-546.
88. Westerheide SD, Louis-Plence P, Ping D, He XF and Boss JM. (1997). J. Immunol., 158, 4812-4821.
89. Wintzer HO, Benzing M and von Kleist S. (1990). Br. J. Cancer, 62, 289-295.
90. Yazawa T, Ito T, Kamma H, Suzuki T, Okudela K, Hayashi H, Horiguchi H, Ogata T, Mitsui H, Ikeda M and Kitamura H. (2002). Am. J. Pathol., 161, 291-300.
91. Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K and Ogata T. (1999). J. Pathol., 187, 191-199.
92. Yazawa T, Kamma H and Ogata T. (1993). Appl. Immunohistochem., 1, 289-296.
93. Zuk JA and Walker RA. (1987). J. Pathol., 152, 275-285.
94. Zuk JA and Walker RA. (1988). J. Pathol., 155, 301-309.